ArticleScientific reports2019
Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models.
Chun-Ting Kuo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it